T63.063D Toxic effect of venom of other North and South American snake, assault, subsequent encounter

Name of the Condition

• Toxic effect of venom of other North and South American snake, assault, subsequent encounter
• ICD-10-CM Code: T63.063D

Summary

This condition describes the adverse health effects resulting from exposure to the venom of non-rattlesnake, non-cobra, and non-sea snake species native to North and South America, where the exposure was due to an assault. The code is used for encounters occurring after the initial treatment of the acute toxic effect, indicating ongoing care for the injury. The focus is on the residual or healing phase of the venom-related toxicity.

Causes

The condition is caused by the injection of venom from a North or South American snake into the body, usually via a bite, as a result of an assault. Venom contains various toxins that can affect multiple organ systems, leading to systemic or localized reactions. The subsequent encounter code applies when the patient is receiving follow-up care for the injury.

Risk Factors

• Exposure to venomous snakes in natural or controlled environments during an assault.
• Activities in snake habitats (e.g., hiking, farming, or handling snakes) that may increase risk of assault involving snakes.
• Lack of protective measures (e.g., wearing appropriate footwear or clothing) during such encounters.

Symptoms

• Localized pain, swelling, and discoloration at the bite site.
• Systemic effects such as nausea, vomiting, dizziness, or muscle weakness.
• Neurological symptoms (e.g., blurred vision, difficulty breathing, or paralysis) in severe cases.
• Hemotoxic effects (e.g., bleeding, bruising, or coagulation abnormalities).

Diagnosis

Diagnosis is based on clinical evaluation, including patient history of snake exposure and physical examination. Laboratory tests may assess organ function, coagulation status, or venom-specific antibodies. Imaging or other studies may be used to evaluate tissue damage or complications.

Treatment Options

Treatment focuses on managing ongoing symptoms and promoting healing. This may include wound care, pain management, and monitoring for complications. Antivenom or other therapies initiated during the acute phase may continue if needed, with adjustments based on clinical response.

Prognosis and Follow-Up

Prognosis depends on the severity of the initial venom exposure and the timeliness of treatment. Most patients recover with appropriate care, but some may experience lasting effects. Follow-up care ensures resolution of symptoms and addresses any residual issues.

Complications

• Persistent pain, numbness, or weakness in the affected area.
• Chronic swelling, discoloration, or tissue damage at the bite site.
• Systemic issues such as ongoing neurological deficits, organ dysfunction, or coagulation abnormalities.
• Psychological effects related to the assault experience.

Lifestyle & Prevention

• Avoid areas known to have venomous snakes, especially during high-risk activities.
• Wear protective clothing and footwear when in snake habitats.
• Seek immediate medical attention if a snake bite occurs, even if symptoms are mild.

When to Seek Professional Help

Seek medical care if symptoms worsen, new symptoms develop, or if there are signs of infection or tissue damage at the bite site. Prompt evaluation is important for managing complications or residual effects.

Tips for Medical Coders

Use this code for subsequent encounters related to the toxic effect of venom from other North and South American snakes due to an assault. Ensure documentation supports the nature of the encounter (e.g., follow-up care) and the underlying cause (assault-related venom exposure). Verify that the code aligns with the patient’s current clinical status and treatment phase.